HVN Medicine
The computed 12-month bankruptcy probability of HVN Medicine is 3.1% (moderate). The 2024 annual accounts show equity of €153k and a net result of €86k. The company has been active since 2023 and the Belgian State Gazette contains no insolvency or warning signals.
| Equity | €153k |
| Net result | €86k |
| Active | 3 yrs |
| Locations | 1 |
Exceptional profile, strong across almost every axis.
All 5 axes are computed from data Checked has read.
Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?
The full score breakdown, per-year score history and the indicative credit limit are in Kantoor S.
See plans →Show 9 other metrics
| Fiscal year | 2024 |
|---|---|
| Deposit | micro |
| Revenue | - |
| EBITDA | €121k |
| Net profit | €86k |
| Cash flow | €93k |
| Staff costs | - |
| Income taxes | €28k |
| Dividends | - |
| Total assets | €215k |
| Equity | €153k |
| Debt | €62k |
| of which ≤ 1y | €59k |
| of which > 1y | €2k |
| Working capital | €134k |
| Employees (FTE) | - |
| 2024 | |
|---|---|
| Current ratio | 3.25 |
| Quick ratio | 3.25 |
| Working capital ratio | 62.4% |
| Solvency | 71.1% |
| Debt / equity | 0.41 |
| Long-term debt ratio | 0.02 |
| Interest coverage | 289.27 |
| Gross margin | - |
| Net margin | - |
| ROA | 40.0% |
| ROE | 56.3% |
| EBITDA margin | - |
| Days sales outstanding | - |
| Days payable outstanding | - |
| Inventory turnover | - |
| Days inventory (DSI) | - |
Full annual accounts (23 line items)
| Line item | Code | 2024 |
|---|---|---|
| Balance sheet, Assets | ||
| TOTAL ASSETS | 20/58 | €215k |
| Fixed assets | 21/28 | €20k |
| Formation expenses | 20 | €682 |
| Tangible fixed assets | 22/27 | €20k |
| Current assets | 29/58 | €193k |
| Cash & bank | 54/58 | €192k |
| Balance sheet, Equity & liabilities | ||
| TOTAL EQUITY & LIABILITIES | 10/49 | €215k |
| Equity | 10/15 | €153k |
| Contributions / capital | 10/11 | €2k |
| Reserves | 13 | €80k |
| Accumulated profits (losses) | 14 | €71k |
| Amounts payable | 17/49 | €62k |
| Amounts payable after one year | 17 | €2k |
| Amounts payable within one year | 42/48 | €59k |
| Trade debts payable within one year | 44 | €102 |
| Income statement | ||
| Gross operating margin | 9900 | €122k |
| Operating result | 9901 | €114k |
| Financial income | 75 | €6 |
| Financial charges | 65 | €419 |
| Result before taxes | 9903 | €114k |
| Income taxes | 67/77 | €28k |
| Net result for the period | 9904 | €86k |
| Result to be appropriated | 9905 | €86k |
| NACE primary | - |
| Legal form | Private limited company(610) |
| Incorporation | 04-01-2023 |
| Status | Active |
| Postal code | 1470 |
Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 25744E1088/00A000 | Wallonia | 1.9 ha | 1 · 8,394 m² | 33.6 m · 6 fl. |
| 25003M0251/00S000 | Wallonia | 3,200 m² | 1 · 155 m² | 7.2 m · 2 fl. |
A single timeline of everything that happened to this company, publications, insolvency and lifecycle events, administrative changes and filed annual accounts.
We know of 2 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
27-01-2026 Registered office moved from Auderghem to Baisy-Thy
- avenue de Beaulieu 10, 1160 Auderghem → avenue des Dauphins 27, 1470 Baisy-Thy
Technical details
{
"events": [
{
"kind": "zetel_transfer",
"seat_type": "statutaire",
"new_address": {
"city": "Baisy-Thy",
"region": "Brussels",
"street": "avenue des Dauphins",
"country": "BE",
"postcode": "1470",
"box_number": null,
"street_number": "27"
},
"old_address": {
"city": "Auderghem",
"region": "Brussels",
"street": "avenue de Beaulieu",
"country": "BE",
"postcode": "1160",
"box_number": "3",
"street_number": "10"
},
"effective_date": "2025-11-02",
"evidence_quote": "d\u00E9cide, conform\u00E9ment \u00E0 l\u0027article 2 des statuts, de transf\u00E9rer le si\u00E8ge de ladite soci\u00E9t\u00E9 d\u0027Auderghem (1160 Bruxelles), avenue de Beaulieu, 10 bo\u00EEte 3, \u00E0 1470 Baisy-Thy, avenue des Dauphins, 27, \u00E0 compter du 02 Novembre 2025."
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0795.742.567",
"name_full": "HVN MEDICINE",
"legal_form": "SRL"
}
}06-01-2023 Incorporation of a new SRL
Technical details
{
"kind": "oprichting",
"seat": "1160 Auderghem, Avenue de Beaulieu 10 bte 3",
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"founders": [
{
"org": null,
"kind": "natural_person",
"person": {
"dob": "1987-01-20",
"name": "Madame VAN NOTEN H\u00E9lo\u00EFse Madeleine Ghislaine Ginette L\u00E9onie",
"niss": null,
"address": "1160 Auderghem, avenue de Beaulieu, 10 bo\u00EEte 3"
},
"share_class": "Ordinary",
"partner_role": null,
"holder_org_kbo": null,
"holder_org_name": null,
"contribution_type": "cash",
"amount_paid_in_eur": 2000,
"holder_person_name": "Madame VAN NOTEN H\u00E9lo\u00EFse Madeleine Ghislaine Ginette L\u00E9onie",
"is_subscriber_only": false,
"n_shares_subscribed": 100,
"amount_subscribed_eur": 2000,
"is_anonymous_silent_partner": false
}
],
"capital_eur": 2000,
"subject_company": {
"kbo": "0795.742.567",
"name_full": "HVN Medicine",
"legal_form": "SRL"
},
"initial_directors": [],
"incorporation_date": "2023-01-04",
"post_incorporation_mandates": []
}| Legal nameFR | HVN Medicine |